NAPKON Vaccination Module
1.0.0 - trial-use
NAPKON Vaccination Module
1.0.0 - trial-use
NAPKON Vaccination Module - Local Development build (v1.0.0). See the Directory of published versions
COVID-19 immunization event
Whether a vaccination caused an allergic reaction
Pain intensity at vaccine injection site at rest or movement
Size of an erythema at a vaccine injection site
Size of an swelling at a vaccine injection site
Maximal body temperature after a vaccination event (indicating fever)
Whether a patient took analgesic or antipyretic drugs after a vaccination event
General complaints after a vaccination event
Whether a patient underwent medical treatment for a potential or actual adverse reaction to a vaccination event
Whether a patient underwent medical treatment for COVID-19
Profile to capture the diagnosis of disease caused by 2019 novel coronavirus.
Variant/strain of detected SARS CoV2 (Pango Cov-lineage)
Indicating whether a COVID-19 patient received an oxygen therapy
Whether a patient regularly drinks alcohol
How many alcoholic drinks a patient usually drinks per day
Whether a patient is or has been receiving a chemotherapy within the last 3 months
Whether a patient is receiving an immunosuppressive or -modulatory therapy
Response to AdditionalVaccinationWillingnessQuestionnaire
IG © 2021+ Charité - Universitätsmedizin Berlin. Package napkon-vaccination#1.0.0 based on FHIR 4.0.1. Generated 2021-12-10
Links: Table of Contents |
QA Report |
Issues |
Submit an issue |
Version History |
|